Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
An open-label pilot study of psilocybin-assisted therapy for binge eating disorder.
Journal: Journal of eating disorders
Published: September 16, 2025
Functional and Metagenomic Evaluation of Ibezapolstat for Early Evaluation of Anti-Recurrence Effects in Clostridioides difficile Infection.
Journal: Antimicrobial agents and chemotherapy
Published: July 21, 2022
Efficacy, Safety, Pharmacokinetics, and Microbiome Changes of Ibezapolstat in Adults with Clostridioides difficile Infection: A Phase 2a Multicenter Clinical Trial.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: November 16, 2021
A randomized, double-blind, placebo-controlled, single and multiple ascending dose Phase 1 study to determine the safety, pharmacokinetics and food and faecal microbiome effects of ibezapolstat administered orally to healthy subjects.
Journal: The Journal of antimicrobial chemotherapy
Published: December 18, 2019
Discovery and development of DNA polymerase IIIC inhibitors to treat Gram-positive infections.
Journal: Bioorganic & medicinal chemistry
Published: April 22, 2019
A Proposed New Classification of Skin and Soft Tissue Infections Modeled on the Subset of Diabetic Foot Infection.
Journal: Open forum infectious diseases
Published: October 30, 2016
Safety, tolerability and pharmacodynamics of a novel immunomodulator, MIS416, in patients with chronic progressive multiple sclerosis.
Journal: Multiple sclerosis journal - experimental, translational and clinical
Published: October 21, 2014
A phase 1 open-label, sequential dose-escalation study investigating the safety, tolerability, and pharmacokinetics of intravenous TLC388 administered to patients with advanced solid tumors.
Journal: Investigational new drugs
Published: August 09, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026